Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
โ
11.68%
40%
โ
โ
Every year
โ
5 Years
Scoreโ
Net Growth11.68%
Net Trend40%
Net Income Consistencyโ
Rev Growthโ
Rev TrendEvery year
Revenue Consistencyโ
See the full market ranking โ
Iovance Biotherapeutics Inc fundamental performance
Across Iovance Biotherapeutics Inc's full reported history, from 2010 to 2025, net income went from -$ 1M to -$ 390M. Revenue increased in 33% of the years measured; net income in 25%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 6.52 | โ |
1 Year2025-08-13 | $ 2.45 | 166.12% |
5 Years2021-08-13 | $ 21.77 | -70.05% |
10 Years2016-08-12 | $ 9.05 | -27.96% |
All Time2010-10-15 | $ 110.00 | -94.07% |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | 10 Years2016-08-12 | All Time2010-10-15 |
|---|---|---|---|---|---|
| Price | $ 6.52 | $ 2.45 | $ 21.77 | $ 9.05 | $ 110.00 |
| Return | โ | 166.12% | -70.05% | -27.96% | -94.07% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 324M | -$ 289M | $ 297M |
| 2025 | $ 263M | -$ 390M | $ 296M |
| 2024 | $ 164M | -$ 372M | $ 323M |
| 2023 | $ 1M | -$ 444M | $ 279M |
| 2022 | $ 238K | -$ 389M | $ 471M |
| 2021 | $ 0.00 | -$ 327M | $ 504M |
| 2020 | $ 0.00 | -$ 259M | $ 629M |
| 2019 | $ 0.00 | -$ 187M | $ 307M |
| 2018 | $ 0.00 | -$ 123M | $ 468M |
| 2017 | $ 0.00 | -$ 92M | $ 145M |
| 2016 | $ 0.00 | -$ 52M | $ 166M |
| 2015 | $ 0.00 | -$ 27M | $ 103M |
| 2014 | $ 0.00 | -$ 12M | $ 44M |
| 2013 | $ 0.00 | -$ 25M | $ 19M |
| 2012 | $ 0.00 | -$ 3M | |
| 2011 | $ 0.00 | -$ 25M | $ 519.61K |
| IPO2010 | -$ 1M | $ 1M |
Explore beyond IOVA
You're looking at Iovance Biotherapeutics Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
